Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 8/20 | 0.66 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.66 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | GALR3 | O60755 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30688242 | 1.00 | ALOX15 (0.66) | ALOX15ALOX12HPGDMEN1LMNA | |
| SCHEMBL5951224 | 0.83 | ALOX15 (0.54) | ALOX15ALOX12HPGDMEN1LMNA | |
| SCHEMBL74689 | 0.81 | MAOB (0.61) | ALOX15ALOX12HPGDMEN1HTT | |
| SCHEMBL29744489 | 0.81 | MAOB (0.61) | ALOX15ALOX12HPGDMEN1HTT | |
| SCHEMBL17366241 | 0.81 | ALOX15 (0.52) | ALOX15ALOX12HPGDMEN1LMNA | |
| SCHEMBL46705 | 0.79 | TTR (0.47) | ALOX15ALOX12HPGDMEN1LMNA | |
| SCHEMBL20550743 | 0.79 | ALOX15 (0.76) | ALOX15ALOX12HPGDMEN1LMNA | |
| SCHEMBL13580946 | 0.76 | ALOX15 (0.47) | ALOX15ALOX12HPGDMEN1LMNA | |
| SCHEMBL282961 | 0.76 | ALDH1A1 (0.56) | ALOX15ALOX12HPGDMEN1LMNA | |
| SCHEMBL129673 | 0.76 | AR (0.49) | ALOX15ALOX12HPGDMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 942 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11185480-B2 | Buffered microencapsulated compositions and methods | PREMIER DENTAL PRODUCTS COMPANY (US) | 2021-11-30 | — | — | US | claimed |
| EP-3765036-A1 | BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS | Premier Dental Products Company (US) | 2021-01-20 | — | — | EP | claimed |
| US-10688026-B2 | Buffered microencapsulated compositions and methods | PREMIER DENTAL PRODUCTS COMPANY (US) | 2020-06-23 | — | — | US | claimed |
| US-20200016051-A1 | BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS | FIDELITY DIRECT LENDING LLC, AS ADMINISTRATIVE AGENT | 2020-01-16 | — | — | US | claimed |
| WO-2019177927-A1 | BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS | PREMIER DENTAL PRODUCTS COMPANY (US) | 2019-09-19 | — | — | WO | claimed |
| US-20190099335-A1 | BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS | PREMIER DENTAL PRODUCTS COMPANY | 2019-04-04 | — | — | US | claimed |
| US-20180200164-A1 | BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS | FIDELITY DIRECT LENDING LLC, AS ADMINISTRATIVE AGENT | 2018-07-19 | — | — | US | claimed |
| EP-2152845-B1 | HARD SURFACE CLEANING COMPOSITION WITH HYDROPHILIZING AGENT AND METHOD FOR CLEANING HARD SURFACES | SOLVAY USA INC (US) | 2017-03-29 | — | — | EP | claimed |
| US-20150335557-A1 | ANTI-PLAQUE ORAL COMPOSITIONS | BHUSNAN RAJIV (US) | 2015-11-26 | — | — | US | claimed |
| EP-2934694-A1 | ANTI-PLAQUE ORAL COMPOSITIONS | Bhushan, Rajiv (US) | 2015-10-28 | — | — | EP | claimed |
| WO-2003089561-A2 | COMPOSITIONS COMPRISING A DISPERSANT AND MICROCAPSULES CONTAINING AN ACTIVE MATERIAL | THE PROCTER & GAMBLE COMPANY (US) | 2003-10-30 | — | — | WO | claimed |
| US-6616922-B2 | For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user | THE DIAL CORPORATION | 2003-09-09 | — | — | US | claimed |
| US-20030022941-A1 | For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user | Henkel IP & Holding GmbH (DE) | 2003-01-30 | — | — | US | claimed |
| US-20020090349-A1 | Process for the biocidal treatment of surface | BERGERON VANCE (FR) | 2002-07-11 | — | — | US | claimed |
| WO-2001093820-A1 | ANTIPLAQUE AQUEOUS ORAL COMPOSITION | RHODIA CHIMIE (FR) | 2001-12-13 | — | — | WO | claimed |
| US-5665333-A | Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth | PROVSEAL LLC | 1997-09-09 | — | — | US | claimed |
| US-5279813-A | Solid polyethylene or polyethyleneterephthalate | COLGATE-PALMOLIVE COMPANY (US) | 1994-01-18 | — | — | US | claimed |
| US-5273741-A | Bactericide of water-insoluble noncationic halogenated diphenyl ether and stabilizer in a compatible dispenser of polyethylene or polyethylene terephthalate | COLGATE-PALMOLIVE COMPANY (US) | 1993-12-28 | — | — | US | claimed |
| US-5167951-A | Stabilizer of halogenated diphenyl ether bactericide | COLGATE-PALMOLIVE COMPANY (US) | 1992-12-01 | — | — | US | claimed |
| US-5135738-A | Polyethylene or PET dispenser with halogenated diphenyl ether bactericide and stabilizer | COLGATE-PALMOLIVE COMPANY (US) | 1992-08-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10688026-B2 | Buffered microencapsulated compositions and methods | LIPA, CHMP4B, APOB | ALOX15 860/4885ALOX12 1164/4885HPGD 2041/4885 |
| US-11185480-B2 | Buffered microencapsulated compositions and methods | CHMP4B, LIPA, APOB | ALOX15 1317/4885ALOX12 1765/4885HPGD 2167/4885 |
| US-20150335557-A1 | ANTI-PLAQUE ORAL COMPOSITIONS | MGMT, CAPG, TRPM7 | ALOX15 4346/4885ALOX12 4049/4885HPGD 1333/4885 |
| US-20180200164-A1 | BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS | LIPA, CHMP4B, APOB | ALOX15 860/4885ALOX12 1164/4885HPGD 2041/4885 |
| US-20030022941-A1 | For use in cleansing formulations to cleasne the skin and to destroy bacteria and other microorganisms present on the skin, especially the hands, arms, and face of the user | CUTA, CHIT1, CLSPN | ALOX15 496/4885ALOX12 285/4885HPGD 3810/4885 |
| US-20200016051-A1 | BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS | CHMP4B, LIPA, APOB | ALOX15 1317/4885ALOX12 1765/4885HPGD 2167/4885 |
| US-20190099335-A1 | BUFFERED MICROENCAPSULATED COMPOSITIONS AND METHODS | LIPA, CHMP4B, APOB | ALOX15 1153/4885ALOX12 1541/4885HPGD 1924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.